States Chronicle - Latest Breaking World News

Saturday, March 6, 2021
Log in
  • About Us
  • Contact Us
  • Authors
  • Investor Relations
  • Privacy
  • Terms of Use
  • Latest News
    • Right Colors for your Skin Tone
    • MOST ACTIVE NASDAQ After-Hours
    • iPhone 5C Release Date
    • Samsung Galaxy S5 Release Date
    • The History of the Atkins Diet

Diabetic drug DPP-4 don’t raise heart-attack risk but have heart failure links

September 2, 2013 By Janet Vasquez Leave a Comment

Email, RSS Follow

The scientists on Monday found a mixed safety report of a diabetes pills as the studies showed them as not a potent accelerator of heart attacks but simultaneously its link to heart failure was not denied in the report.

The studies presented on Monday at the European Society of Cardiology Congress investigated a newer class of drugs known as DPP-4 inhibitors, which are supposed to help bring diabetics’ blood sugar into the normal range. Both studies were also published on Monday in the New England Journal of Medicine.

Two studies were conducted independently of each other to verify the safety standards of the drugs. One of the trials, known as Savor Timi-53, was a 16,492-patient study on the medication saxagliptin, marketed by Bristol-Myers Squibb Co. BMY -0.24% and AstraZeneca AZN.LN +0.08% PLC as Onglyza. Patients with Type 2 diabetes and who had a history of or were at risk for cardiovascular events were randomized to the medicine or a placebo, in addition to other standard treatment for their diseases. They were followed for an average of two years.

pills1

The other study, called Examine, was a randomized study of alogliptin—Takeda Pharmaceutical Co. 4502.TO +1.12% and Sanofi SA’s SAN.FR +2.08% Nesina—in nearly 5,400 patients for an average of 18 months.

Both the studies found similar outcomes on the main endpoint of heart attack: The gliptins didn’t increase heart attack risk compared with placebo but also didn’t lower risk.

However, there was a statistically significant difference in heart-failure hospitalizations with Onglyza: 3.5% for the group taking the medicine compared with 2.8% for the control group.

“It is a little bit concerning,” said Dr. Christopher Grainger of Duke University Medical Center, who was not involved in the research. “I’m sure the FDA (U.S. Food and Drug Administration) will want to know more about it.”

The findings also raise questions about whether drugs that only lower blood sugar, without addressing cholesterol, blood pressure or lifestyle factors, are enough to improve heart health. Previous small trials had suggested a possible benefit from lowering blood sugar.

Drugs like Onglyza and Nesina work by inhibiting dipeptidyl peptidase-4, or DPP-4, to enhance the body’s ability to lower elevated levels of blood sugar.

Various

DDP-4s are not the most powerful agents for lowering blood sugar levels but they are well tolerated and have proved an attractive option for doctors looking for new oral drugs.

The DPP-4 market is dominated by Merck’s Januvia, which has annual sales of around $5 billion, including a related combination treatment called Janumet. But growth of the class has slowed this year, partly on concerns over pancreatic safety.

In 2008, the U.S. Food and Drug Administration issued guidance that drug makers needed to demonstrate that new diabetes drugs wouldn’t lead to an “unacceptable increase in cardiovascular risk.” In 2010, Avandia was removed from the market in Europe and its use was restricted in the U.S. But in June, a Duke University study was published suggesting there was no increase in cardiovascular events with Avandia, and an expert committee advised the FDA to ease restrictions on use.

 

Email, RSS Follow

Filed Under: Health Tagged With: diabetic drugs, diabetic pills, diabetic risk, DPP-4

About Janet Vasquez

Janet hasn’t had the happiest of childhoods. Her parents shipped her off to a girl-only boarding school when she was merely a child. After a few years spent with the nuns she unexpectedly remained pregnant and was kicked from the school. But this didn’t hinder her.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 30 other subscribers

Doom and MiniDoom 2

Volunteer-Based Mexican Studio Releases Sidescrolling Doom Clone

March 12, 2018 By Georgia Dawson Leave a Comment

Chinese Mom and locked iPhone.

Toddler Locks Chinese Mom Out of Phone for Half a Century

March 9, 2018 By James Faulkner Leave a Comment

Alexa laughing

Amazon Alexa Laughing out of the Blue Puzzles Engineers

March 8, 2018 By Jack M. Robinson Leave a Comment

Flippy and the Burgers

Meet Flippy, World’s First Fast-Food Robotic Chef

March 6, 2018 By Georgia Dawson Leave a Comment

System Shock

System Shock Remastered Delayed, Nightdive Studios CEO Announces

February 19, 2018 By Janet Vasquez Leave a Comment

Sea of Thieves.

Sea of Thieves Optimized for Low-End PCs

February 14, 2018 By Georgia Dawson Leave a Comment

Sony and VR

Sony Touts New Generation of VR Controllers

January 31, 2018 By Deborah Cobing Leave a Comment

YouTube

YouTube Stiffens Its Monetization Policy to Discourage Spammers and Bad Actors

January 18, 2018 By Georgia Dawson Leave a Comment

Google Art Doppelganger

Google App Can Now Show Your Art Doppelganger

January 15, 2018 By Troy Rubenson Leave a Comment

YouTube mobile app logo on a smartphone

YouTube Now Enables Vertical Videos on iOS

December 24, 2017 By Janet Vasquez Leave a Comment

Samsung Galaxy S2 with a shattered screen

Cracked Smartphone Screens Are a Thing of the Past – Self-Healing Polymer Gets Fixed Just by Pressing It

December 20, 2017 By Janet Vasquez Leave a Comment

Bing logo on a white background

Bing Improves Its Search Results with the Help of AI and Reddit Integration

December 16, 2017 By Janet Vasquez Leave a Comment

White hashtag on a blue background

Follow Your Interests on Instagram by Directly Following Hashtags

December 14, 2017 By Janet Vasquez Leave a Comment

Samsung Galaxy S7 Edge on a leather seat

Samsung Galaxy Smartphones Make More People Happier as Compared to iPhones

December 13, 2017 By Janet Vasquez Leave a Comment

Related Articles

  • image of retina

    Laser Pointer Makes Hole in Little Boy’s Retina

    Jun 21, 2018
  • person playing a video game

    World Health Organization Officially Recognizes Gaming Disorder

    Jun 19, 2018
  • two robot hands

    Sex Robots Don’t, In Fact, Provide Any Heath Benefits (Study)

    Jun 6, 2018
  • women's health initiative logo

    Some Breast Cancer Patients Can Skip Chemotherapy (Study)

    Jun 4, 2018
  • bowl of vitamin supplements

    Vitamin and Mineral Supplements are Useless (Study)

    May 31, 2018
  • two cockroaches on a leaf

    Cockroach Milk, The Latest Superfood Trend

    May 29, 2018
  • seafood on platter

    Seafood Boosts Libido and Fertility (Study)

    May 25, 2018
  • Vitamin D pills

    Vitamin D Therapy to Treat Diabetes and Cancer (Study)

    May 14, 2018
  • woman with a runny nose

    Woman’s Runny Nose Was Actually Brain Fluid Leak

    May 8, 2018
  • children running

    Children are in Better Shape than Athletes (Study)

    Apr 25, 2018

Categories

  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Markets
  • National News
  • Nature
  • News
  • Politics
  • Science
  • Technology
  • Uncategorized
  • World

Copyright © 2021 statechronicle.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.